Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%

Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%

Submitted by admin on December 5, 2019 - 10:11am
Source: 
Xconomy
News Tags: 
SAGE Therapeutics
clinical trials
SAGE-217
major depressive disorder
Headline: 
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
snippet: 

An experimental Sage Therapeutics drug intended to alleviate depression symptoms quickly has failed to beat a placebo in a pivotal study, the company reported Thursday.

Do Not Allow Advertisers to Use My Personal information